In a previous paper (1) we demonstrated ,quantitatively the increased susceptibility of the red cells of patients with paroxysmal nocturnal hemoglobinuria (PNH) to lysis by specific antibody and complement. PNH cells were found to consist of two populations of red cells, one which was about 25 times as sensitive to complement lysis as normal cells, the other only slightly more sensitive than normal cells. The purpose of the present study is to elucidate the relative roles of complement (C') and antibody in accounting for this increased sensitivity.
The increased susceptibility of PNH cells to lysis by complement and antibody has been attributed to the ability of these cells to take up a greater amount of antibody, as suggested by higher agglutination titers when these cells were used (2) . The present experiments indicate that increased antibody uptake does not play a major role in the increased sensitivity of PNH cells to complement lysis. The increased sensitivity appears to be due, then, to a greater susceptibility of the cell to the action of C', or to a greater efficiency of the reactions of C' once the sequence of reactions has been begun by antibody.
Differences in efficiency of C' activity theoretically could occur in any of the complex reac-tions of the components of complement (designated C'1, C'2, C'3, or C'4). These reactions are presently understood to occur as follows (3) : E (red cell) + A (antibody) -EA. Ca+ EA + C '1 EAC', * EAC'ja (4) (addition and activation of C'1). EAC'ia + C'4 ) EAC'la,4 (addition of C'4). [1] [2] [3] Mg++ EAC'ia,4+C'2 )EAC'la,4,2 )EAC'la,4,2a [4] (addition and activation of C'2). The return of EAC'la.4,2a to EAC'ia,4 is a degradation reaction the rate of which is heat dependent (5). [5] EAC'la.4,2a + C'3 components' -EAC'la,4,2a,3 or E*p (E*, is the precursor form of red cells irreversibly damaged by the action of complement). [6] heat E*p > E*a (activated form). E*p and E*a will not lyse unless the concentration of EDTA is reduced below 0.09 mole per L (7). [7] E*a ) E*o. E*o will not lyse in the presence of 25% wt/vol serum albumin (8) . [8] E*o ) ghosts and hemoglobin. [9] In the course of this complex series of reactions, apparent differences in the efficiency of complement could occur due to differences in the cells upon which the reactions take place. The results of the present investigations of some of the reactions of C' components indicate that the efficiency of complement component reactions in the early reactions of the sequence are the same on normal and PNH cells and that the greater efficiency of complement in lysing PNH cells must, therefore, be due to differences in the final reactions of the sequence.
Methods
Red cells. Red blood cells were collected, preserved, and prepared for use in the manner outlined in the previous paper (1) . The standard suspension containing approximately 2 X 108 cells per ml was prepared in the same manner as outlined.
Antibody. The anti-I antibody of exceptional hemolytic potency used in the previous work (1) ED TA. The disodium salt of ethylenediaminetetraacetic acid was prepared and stored as an isosmotic 0.09 M solution, the pH of which was adjusted to 7.5 with concentrated NaOH. Dilute solutions of this were made with isotonic VSB lacking calcium and magnesium.
Sucrose. Isotonic sucrose buffer was made by dissolving 48.6 g of sucrose and 0.5095 g of Na 5,5-diethylbarbituric acid (sodium barbital) in 500 ml of distilled water. The pH was adjusted to 7.4 with concentrated HCl. Calcium and magnesium ions and gelatin were added to the same concentrations as in VSB at the time of use. Solutions of reduced ionic strength were prepared by mixing appropriate amounts of isotonic sucrose buffer and isotonic VSB (9) .
Optimal dilution of antibody. The dilution of antibody which, used in the presence of a fixed quantity of C', will lyse the greatest number of normal cells, was determined as outlined in the previous paper (1) . This was 1 in 40 dilution for the anti-I antibody used for most experiments.
Complement-sensitivity titration. The estimate of the sensitivity of cells to complement lysis was performed as outlined in the previous paper (1) .
Hemolytic antibody titration. The hemolytic antibody titer of solutions containing anti-I antibody was determined by appropriate modification of Mayer's technique (3) for the determination of the hemolytic antibody titer of rabbit antisheep red cell antiserum. The red cells of patients with PNH were used; the proportion of sensitive cells was estimated by the complement lysis sensitivity test or by a preliminary antibody titration involving a wide range of antibody dilutions. After preliminary experiments, a basic dilution and three doubling dilutions of antibody were selected to give, insofar as possible, partial lysis of the sensitive cells in all tubes. Five-tenths ml of PNH cells in a concentration half that of the standard suspension (i.e., 1.1 X 108 cells per ml) was added at 00 C to 0.5-ml volumes of the antibody in an initial and three doubling dilutions. Exactly 1 minute later, 0.25 ml of ice-cold whole human serum was added as a source of complement. After incubating for exactly 12 minutes at 0°C, the tubes were transferred to the 370 C water bath; exactly 15 minutes later 2.5 ml of cold 0.01 M EDTA buffer was added, and the tubes were placed at 00 C and centrifuged in the cold. When multiple samples were assayed, pipettings of each series of four tubes were spaced at intervals of 1 minute so that the time relationship could be maintained accurately. The hemolysis in each tube was determined, after centrifugation, in the spectrophotometer at a wavelength of 541 mrn, and the fraction of the sensitive cells lysed (y) was calculated. The Von Krogh equation was used to correct for the sigmoid shape of the curve. When the logarithm of y/(1 -y) was plotted against the logarithm of the relative dilution of antibody, a straight line resulted. The dilution at which the line intersected 1.0 represented the dilution producing 50% hemolysis under these conditions. Therefore, the unit of antibody was defined as the dilution of antiserum 0.5 ml of which, in the presence of 0.25 ml of human serum, lysed 50% of the sensitive cells in 0.5 X 108 PNH red cells in 15 minutes after incubation for 12 minutes at 00. The value obtained varied with the PNH cells used and hence was relative. In all comparable experiments described below, the hemolytic antibody titer was determined with the cells of the same PNH patient; in most cases, the proportion of sensitive cells was greater than 80%.
Determination of the adsorption of antibody on red cells.
The ability of the anti-I antibody 'used in these experiments to combine with various types of human red cells was tested by a modification of Mayer's inhibition assay (3) . For each specimen of red cells to be tested standard suspensions containing 2 X 108 red cells per ml were prepared and diluted with isotonic VSB in doubling dilutions to 1 in 16, (i.e., to 0.125 X 108 cells per ml). One ml of each of these suspensions was mixed at 00 C with 1 ml of an antibody solution containing 15 hemolytic units (AbH6o)
per ml, determined as outlined above. The cells and antibody were allowed to react for 30 minutes and were centrifuged at 00 C. The hemolytic antibody titer of the supernatant fluid was determined as above, and the percentage of the original antibody remaining in the supernatant fluid after incubation was plotted against the number of red cells used in adsorption. C'la fixation and transfer test. The amount of purified first component of complement (C'la) fixed by anti-I antibody on normal and PNH cells was determined by the C'la fixation and transfer test of Borsos and Rapp (10) as modified by Rosse, Borsos, and Rapp (11) . One-tenth ml of a suspension of test cells in 60% isotonic sucrose-40% VSB buffer containing 2.2 X 108 cells per ml was mixed with 0.1 ml of a 1/100 dilution of anti-I antibody in a siliconized tube at 00 C. Three-tenths ml of functionally purified C'la prepared from guinea pig serum by the method of Borsos and Rapp (12) was added and the mixture incubated for 30 minutes. The cells were washed with icecold 60% isotonic sucrose-40% VSB buffer, transferred into a second set of tubes, and washed three more times with this buffer. They were suspended in 1 ml of VSB, ninefold falling dilutions were made, and the amount of C'la present was assayed according to the method of Borsos and Rapp (12) .
The number of C'la molecules present per test cell was calculated from the following formula: x = (2.2 X 108 X z X dilution of C'la X 10)/(2.2 X 107), where x = number of molecules of C'la per test red cell, z = -loge (1 -y), and y = percentage lysis of sheep cells used in assay of C'la.
Determination of the amount of C' bound per unit antibody bound. For determination of the ratio of C' fixed to amount of antibody adsorbed for PNH and normal cells, red cells in known numbers or washed red cell stromata prepared from known numbers of cells by gradual osmotic lysis were suspended in 2 ml of isotonic VSB and were reacted with 1 ml of a dilution of antiserum containing the anti-I antibody and 1 ml of whole normal human serum as a source of C'. This mixture was incubated for various periods of time at 00 or 30 C and the cells or stroma removed by centrifugation at 18,000 rpm for 30 minutes. The supernatant was then divided; one part was heated to 560 C for 30 minutes and assayed for hemolytic antibody activity by the assay described above. The other portion was assayed for C' content, by the sheep cell-rabbit antiserum system described by Mayer (3). Controls, which were treated in the same way, consisted of antibody alone, antibody and complement, complement alone, and complement with cells. The amount of antibody adsorbed by the cells or cell stromata was determined by difference as was the amount of C' fixed. The ratio of complement fixed to antibody adsorbed was calculated.
The degradation rate of C'2 on cellular intermediates. To produce the cellular intermediate "EAC'1.,4,2.",2 we incubated together equal volumes of a standard suspension of red cells in 60% isotonic sucrose-40% VSB and whole human or guinea pig serum at exactly 00 C for periods of 10 to 60 minutes. The cells were then washed three times with 60% isotonic sucrose-40% VSB at 00 C and suspended 2For the purposes of the present paper the notation "EAC'I&,4,2&" (or "SAC'1a,4,2S," where S indicates an antigen site) will be used when the presence of cellular intermediates containing components of C'3 is not excluded by the preparative procedures. When this intermediate is made in such a way that C'3 components are functionally absent (e.g., EAC'1.,4 + purified C'2), the quotation marks will be omitted. Because the status, number, and nomenclature of C'3 components are uncertain, no effort is made to distinguish among them. In the present paper, the presence of one or more but not all components of C'3 on the intermediate EAC'la,4,2. will be indicated by the notation EAC'1.,4,2a,3 componenta. When all C'3 components are present, the notation EAC'.,4,2a,3 or E* will be used. ("EAC'a,4,2i) + 0.5 ml of 0.02 M EDTA in VSB, 0.5 ml of C'-EDTA + 0.5 ml of 60% isotonic sucrose buffer-40% VSB, and 0.5 ml of "EAC'ia,4,2a" + 0.5 ml 0.04%
NH40H. At the end of the incubation the total volume of the mixtures was brought to 3.0 or 4.0 ml with buffer, and the cells were removed by centrifugation. The amount of lysis was determined spectrophotometrically at a wavelength of 412 my and the net lysis determined by subtraction of the appropriate control readings. The fraction lysed, y, was determined by dividing the corrected optical density by that of the completely lysed control. With one completed complement reaction assumed sufficient for the lysis of any one cell, the number of sites, z, per cell in the state "SAC'1.,4, ." that were capable of completing the complement sequence was calculated by the formula, x = -log.
(1 -y), according to Rapp (6) To produce cellular intermediates EAC'1&,4,2a known to be lacking C'3 components, we made "EAC'ia,4,2a" as above, using both normal and PNH cells and guinea pig serum as a source of C' components. These cells were warmed for 120 minutes at 370 C and stored for 2 days at 00 C; they were thus rendered incapable of being lysed by C'-EDTA, i.e., they had decayed to the state EAC'1.,4. Since C'2 is simultaneously added, activated, and destroyed at SAC'.,4 sites at finite rates, there is an optimal time after the addition of purified C'2 to cells in the state EAC'la,4 at which the maximal number of sites in the state EAC'1,,4,2 may be formed. This time, tmax, was determined for normal and PNH cells in the state EAC',.,4 in a manner analogous to that used by Borsos and coworkers (13) . Cells in the state EAC'1.,4 were washed with 60% isotonic sucrose-40% VSB and suspended at 370 C in functionally purified guinea pig C'23 diluted 1 in 20 in 60% isotonic sucrose-40% VSB. At intervals of time, 0.5-ml portions were removed and pipetted into 0.5 ml of guinea pig C' diluted 1 in 10 in 0.01 M EDTA in VSB. After 60 minutes' incubation, the total volume of the mixtures was brought up to 4.0 ml and centrifuged. The amount of lysis was determined with the Unicam spectrophotometer at a wavelength of 412 mI&, and correction was made for spontaneous lysis and for complement color. The fraction of cells lysed was plotted against the time after addition of C'2 at which C'-EDTA was added. The time at which the greatest degree of lysis occurred was determined by inspection.
To determine the rate of degradation of the intermediate EAC'U1,4,2., when the C'2 was supplied in purified form, we made cells in the state EAC'U1,4, as described above using guinea pig serum., These cells were then reacted with equal volumes of purified guinea pig C'2, diluted 1 in 20 in 60% isotonic sucrose-40% VSB, at 370 C for the optimal time, determined as described above. They were then diluted fourfold with ice-cold 60% isotonic sucrose-40% VSB, centrifuged at 00 C, resuspended in the same buffer, and maintained at 00 C. Figure  1 . The relative ability of papainized and PNH The fixation of complement related to antibody adsorbed. In Table III are shown the results of experiments in which the amount of C' and the amount of antibody were measured before and EAC'la,4,2a were present was found to be the same for both normal and PNH cells that had been treated identically (Figure 2 ).
The degradation of "EAC'1.,4,82a". The rate of degradation of "EAC'1a,4,2a" made with human C' and normal and PNH cells is illustrated in Figure 3 . Normal cells from four donors gave a single component exponential curve with a mean t1 of 220 minutes (range, 164 minutes to 251 minutes). The cells from three patients with PNH each gave two-component curves, a slow EAC'la,4,2a made from normal and PNH cells and guinea pig C' components were found to have the same rate of degradation, corresponding to that of the rapidly decaying component seen with PNH cells ( Figure 5 ). This strongly suggests that the slow rate of degradation seen with normal cells and with part of the PNH cells was in fact due to the presence of cells in the state EACila, 4 cells compared to normal cells or an increased ability of the antigen-antibody combination to initiate complement reactions, i.e., to fix C'1. From the adsorption experiments, it appears that somewhat more antibody is removed from solution by a given number of PNH cells than normal cells. This would suggest that PNH cells have somewhat increased affinity for antibody under these conditions. Costea, Yakulis, and Heller have also demonstrated a somewhat greater uptake of I3'l-labeled cold-reacting antibody from rabbits on PNH cells (14) . However, this apparent small increase in affinity for antibody binding does not result in an increase in fixation of C'la. Hence normal and PNH cells do not appear to differ significantly in their ability to fix C'la and thus initiate C' reactions.
On the other hand, normal cells that have been papainized adsorb larger amounts of antibody from solution than normal or PNH cells. These cells fix two and one-half times as much C'la under the same conditions as normal or PNH cells. This markedly increased affinity for antibody may well explain the twofold increase in complement lysis sensitivity seen with papainized cells (see Table I ). It is evident, however, that differences in antibody affinity or ability to initiate complement reactions cannot explain the 25-fold difference in C' lysis sensitivity between normal and sensitive PNH cells. Hence the reason for this difference must be sought in differences in the effectiveness of complement once the sequence of reactions has been begun.
The early reactions of C' are not only qualitatively the same on the two types of cells but quantitatively the same as well. This means that the same number of C' reactions are begun on normal and PNH cells when the amount of antibody and C' in the reaction mixture is the same. Hence differences in effectiveness of C' must occur late in the complement sequence. Since the same amount of complement (as measured by the titration with sensitized sheep cells) is fixed by normal and PNH cells, the complement sequence must be quantitatively the same on these two types of cells, at least through the step in which C'2 is added. This is because the titer of complement in whole serum is dependent upon the titer of the limiting component or upon limiting reactions in the sequence of complement reactions; in human serum, the limiting component is probably C'2 or one of the C'3 components (6) . Therefore, the fixation of the limiting component and all components that react before it (i.e., at least C'1 and C'4) must be the same for normal and PNH cells. This is confirmed by the studies with addition of C'2. As outlined above, tmax, the time after the addition of C'2 to cells in the state EAC'1a,4 at which the greatest number of cells are in the state EAC'1,4,2a, is related only to the number of sites in the state SAC'ia,4 per cell. Therefore, since the tmax is the same for normal and PNH cells, the number of SAC'la, 4 per cell presumably is the same.
The complex of steps involving C'2 that follows the addition of C'1 and C'4 also appears to be the same for normal and PNH cells. If C'2 is the limiting component or if the limiting component follows the addition of C'2, then the amount of C'2 fixed must be the same for normal and PNH cells treated in the same way. We originally felt that greater efficiency of C' in lysing PNH cells might reside in a slower rate of degradation of EAC'1,4,2a to EAC'la,4. However, when EAC'1a,4,2a is made with functionally pure C'2 in order to exclude the presence of C'3 components, the rate of degradation of this intermediate appears to be the same for normal and PNH cells. Therefore, the difference between these cells in sensitivity to lysis by C' must lie in the final steps of the C' sequence, those involving C'3 and the E* state.
We have little information about the steps involving C'3 components on normal and PNH cells, partly because these steps are themselves only partially understood. Recent work by Yachnin suggests that partially purified C'3 components are more effective in lysing PNH cells than normal cells (15) . This was interpreted to mean that more of the component was adsorbed to the PNH cells than to the normal cell. However, the present work would suggest that if the data are correct, a likely interpretation is that the same amount of C'3 components is adsorbed on normal and PNH cells but that PNH cells lyse because of their remarkable sensitivity to the action of the last components of the complement sequence.
The final steps 'before the lysis of the cells, that is, the formation of membrane defects, are discussed at length in the third paper of this series (16) . Pertinent to the present discussion, though, are the findings that the defects formed in the red cell membrane by the action of C' are the same for normal and PNH cells.
On the basis of these studies, we should like to suggest that the difference between normal and PNH cells in apparent efficiency of C' possibly results from differences in the ease with which the membrane defect (or "hole") responsible for lysis is made. Thus, for the same number of initiated complement reactions, the chances of a membrane defect being formed are many times greater for the sensitive PNH cell than for a normal cell. Summary 1. The relative roles of antibody and complement in the increased sensitivity of paroxysmal nocturnal hemoglobinuria (PNH) cells to complement lysis have been investigated.
2. The amount of anti-I antibody adsorbed by PNH red cells is somewhat greater than that adsorbed by normal cells, but the amount of the activated first component of complement (C'la) fixed by equally sensitized normal and PNH red cells is equal. This suggests that these cells do not differ in the efficiency with which C'la is bound.
3. Papainized normal cells adsorb much greater amounts of antibody and fix at least twice the amount of C'la as normal cells. This probably explains at least in part the somewhat greater sensitivity of these cells to immune lysis.
4. Investigation of several steps of the sequence of reactions involving components of complement indicates that, under the same conditions of antibody and complement concentration and incubation, normal and PNH cells have the same number of sites containing C'1 and C'4 (SAC'a.,4) and fix the same amount of the limiting component of complement (C'2 or one of the C'3 components). The rate of degradation of sensitized red cells bearing complement components la, 4, and 2a (EAC'ia, 4,2a) was the same for the two types of cells. Since the complement steps through the C'2 reactions are quantitatively the same for normal and PNH cells, the increased efficiency of complement in bringing about the lysis of PNH cells is due to differences in the last steps of the sequence of complement reactions, that is, in those steps involving C'3 components and damage to the cellular membrane.
